Form 4: Lexaria Bioscience Corp. Officer Exercises Options, Acquires Shares

Sentiment:

SEC Form 4


Vanessa Carle, Secretary of Lexaria Bioscience Corp., exercised stock options to acquire 2,500 common shares at $1.15 each on May 14, 2024.

Summary

  • On May 14, 2024, Vanessa Carle, the Secretary of Lexaria Bioscience Corp., exercised stock options to acquire 2,500 common shares.
  • The transaction was executed at a price of $1.15 per share.
  • Following the transaction, Carle directly owns 2,567 common shares.
  • Carle also holds warrants for 67 common shares and various stock options with different exercise prices and expiration dates, totaling 60,067 shares.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it's a standard disclosure of an officer exercising stock options. It doesn't inherently indicate positive or negative news.

Positives

  • The exercise of options by an officer may indicate confidence in the company's future prospects.

Industry Context

This filing is a routine disclosure related to insider transactions and provides transparency to the market regarding the holdings of company officers.

Stakeholder Impact

  • The transaction has a minimal impact on stakeholders as it involves a small number of shares relative to the company's total outstanding shares.

Key Dates

DateDescription
11/13/2019Date of Warrants
04/26/2021Date of Stock Options
06/08/2021Date of Stock Options
09/01/2021Date of Stock Options
08/29/2022Date of Stock Options
05/09/2023Shareholder approval received for repricing of stock options
10/26/2023Date of Stock Options
04/26/2024Date of Stock Options
05/14/2024Vanessa Carle exercised stock options
05/15/2024Date of Form 4 filing
11/13/2024Expiration Date of Warrants
04/26/2026Expiration Date of Stock Options
06/08/2026Expiration Date of Stock Options
09/01/2026Expiration Date of Stock Options
08/29/2027Expiration Date of Stock Options
10/26/2028Expiration Date of Stock Options
04/26/2029Expiration Date of Stock Options

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.